Prostate health is one of the most overlooked yet critical areas of concern for aging men. As men enter their 40s and beyond, hormonal shifts, inflammation, and lifestyle changes begin to impact the ...

For patients with locally advanced prostate cancer, combined treatment with chemotherapy and hormonal therapy offers extended control of prostate-specific antigen (PSA) levels, compared to hormonal ...

In recent years, a new treatment strategy known as focal therapy (partial gland ablation) has emerged for prostate cancer considered to be "intermediate risk"—mostly, small tumors confined to one area ...

At a median follow-up of 21.5 months, ADT plus apalutamide significantly prolonged median PSA progression-free survival compared with ADT monotherapy (24.9 vs 20.3 months; hazard ratio [HR], 0.52).

In the quest for optimal health, especially concerning prostate wellness, men often find themselves overwhelmed with options that claim to deliver results. This is where Total Control 24 comes into ...

Adding an experimental immunotherapy to radiation treatment may extend disease-free survival in men with localized intermediate- or high-risk prostate cancer, according to a phase 3 trial. If approved ...

A less-invasive treatment technique called hemi-gland cryoablation (HGCryo) - destroying the areas of the prostate where cancers are located by freezing them - provides a high rate of effective ...

Treatment options for prostate cancer have dramatically expanded. Facing a prostate cancer diagnosis often raises concerns among men and their partners: will treatment affect intimacy and their ...

NEWTOWN, Conn., March 31, 2026 /PRNewswire/ -- Elidah today announced FDA clearance of Elitone for Men, a non-invasive, at-home treatment designed to help men regain bladder control after prostate ...

High-intensity focused ultrasound (HIFU) can help some men with prostate cancer avoid surgery or radiation. In recent years, a new treatment strategy known as focal therapy (partial gland ablation) ...